Recent Updates
Recently added Catalysts
MDXH

MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group

Key Takeaway: COMPANY ANNOUNCEMENT / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, August 8, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced it has signed a health care services agreement with Southern California Permanente Medical Group to

Full Press Release Details

COMPANY ANNOUNCEMENT / REGULATED INFORMATION / INSIDE INFORMATION
IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, August 8, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced it has signed a health care services agreement with Southern California Permanente Medical Group to assess the performance of the ConfirmMDx® for Prostate Cancer test.
Southern California Permanente Medical Group* is a physician-led organization that serves the 4.4 million members of Kaiser Permanente Southern California.
About ConfirmMDx for Prostate Cancer
ConfirmMDx for Prostate Cancer is the first epigenetic, and only tissue-based test in the 2016 NCCN Guidelines for early detection of prostate cancer which addresses false negative biopsy concerns. It is the only molecular diagnostic test that provides a very high negative predictive value (NPV) of 96% for clinically significant prostate cancers, and 90% NPV for all prostate cancers, as well as prostate mapping of the test results to help guide repeat biopsies. Each year, more than 1 million American men undergo an invasive prostate biopsy with a negative result, however approximately 30% of those men have prostate cancer. The current standard of care for prostate biopsy procedures samples less than 1% of the prostate, leaving men at risk for undetected cancer and leading to a high rate of repeat biopsies, even on cancer-free men. ConfirmMDx for Prostate Cancer helps urologists identify low-risk men who may forego an unnecessary repeat biopsy and high-risk men who may benefit from intervention. ConfirmMDx has qualified for Medicare reimbursement and covered by numerous private health insurance plans.
For more information:
Shalon Roth, EVP Corporate Communications
NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx, SelectMDx, AssureMDx, PredictMDx and UrNCollect are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.
*This announcement is not intended to serve as an endorsement of MDxHealth or ConfirmMDx by Kaiser Permanente.

Attachments

ConfirmMDx & Kaiser company announcement...
Last updated: Aug 8, 2017